Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Procter & Gamble Hygiene and Health Care Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholding for the Period Ended March 31, 2016
Procter & Gamble Hygiene and Health Care Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here Q3 results on May 05, 2016
Procter & Gamble Hygiene and Health Care Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 05, 2016, inter alia, to consider and approve Unaudited Financial Results for the quarter and nine months ended March 31, 2016. Resuming manufacturing, sale and distribution of Vicks Action 500 Extra after order of Delhi HC staying the operation of notification dated March 10, 2016
Procter & Gamble Hygiene and Health Care Ltd has informed BSE regarding "Resuming manufacturing, sale and distribution of Vicks Action 500 Extra after order of Delhi HC staying the operation of notification dated March 10, 2016".
P&G; discontinues cold and flu pill Vicks Action 500 Extra after govt ban
P&G discontinued manufacture and sale of its cold and flu pill Vicks Action 500 Extra, following the govt ban on 344 fixed dose combinations Prohibition on manufacture, sale and distribution of Fixed Dose Combination drugs (Paracetamol + Phenylephrine + Caffeine)
Procter & Gamble Hygiene and Health Care Ltd has informed BSE regarding "Prohibition on manufacture, sale and distribution of Fixed Dose Combination drugs (Paracetamol + Phenylephrine + Caffeine)". Procter & Gamble surges on good Q2 numbers
The stock surged 7% to Rs 5,890 after the company posted 62% YoY jump in the net profit at Rs 148 crore in December quarter.
P&G; Q2 net profit up 62% at Rs147 crore
Net sales during the quarter under review stood at Rs713.23 crore, up 10.74% as against Rs644.03 crore in the year-ago period Outcome of Board Meeting
Procter & Gamble Hygiene and Health Care Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 06, 2016, adopted the Policy on Materiality of Events and Information as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Further, the Managing Director in consultation with Legal Head of the Company shall determine the materiality of an event or information... Announces Q2 Results (Standalone), Limited Review Report (Standalone) & Results Press Release for the Quarter ended December 31, 2015
Procter & Gamble Hygiene and Health Care Ltd has announced the following Unaudited Standalone results for the quarter ended December 31, 2015 :The Company has posted a net profit of Rs. 1467.00 million for the quarter ended December 31, 2015 as compared to Rs. 906.60 million for the quarter ended December 31, 2014. Total Income has increased from Rs. 6615.90 million for the quarter ended December 31, 2014 to Rs. 7342.90 million for the quarter ended December 31, 2015.